Filing Flows › Health Care › Leef Brands (LEEEF)
Leef Brands (LEEEF) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 6, 2026 · Leef Brands (LEEEF) Q2 2026 earnings results →
Q2 2026 Revenue down 16% year over year to $7.3M · 18¢ of every $1 of revenue lost · operating margin -27.3%
Leef Brands made $7.3M in Q2 2026 (-16% Y/Y). Operating margin -27.3%, net loss $1.3M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 6, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $7.3M in Q2 2026, down 16% year over year and down 22% from the previous quarter.
Gross margin was 33.1%, up 16.0 points from a year earlier. Operating costs exceeded revenue by $2.0M, an operating margin of -27.3%. Operating expenses grew 14% against a revenue fall of 16%. The fastest-growing cost line was Other operating costs (+20%). The quarter ended with a net loss of $1.3M, wider than the previous quarter's $426K loss. Non-operating items added $1.4M, -215% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$4.1M. Non-cash charges added back $657K of depreciation and amortization and $700K of share-based compensation. Working capital and other items used $4.1M. Capital expenditures of $1.1M exceeded it, leaving free cash flow of −$5.2M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 6, 2026 | $7.3M | -16% | -27.3% | −$1.3M | −$4.1M |
| Q1 2026 | 10-Q | May 6, 2026 | $9.4M | -0.2% | 13.7% | −$426K | $395K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Leef Brands against its Medicinal Chemicals & Botanical Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -16% against the peers' median +7%. Operating margin: -27.3% against the peers' median 0.8%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| LEEEF Leef Brands | Q2 2026 | $7.3M | -16% | -27.3% |
| CURLF Curaleaf Holdings | Q3 2026 | $353M | +11% | 0.8% |
| TLRY Tilray Brands | Q1 FY27 | $257M | +23% | -9.4% |
| TRLV Trulieve Cannabis | Q3 2026 | $230M | -20% | 18.5% |
| USNA Usana Health Sciences | Q2 2026 | $223M | -5% | -9.0% |
| AAWH Ascend Wellness Holdings | Q2 2026 | $126M | -0.9% | 4.2% |
| CRON Cronos Group | Q3 2026 | $83.9M | +72% | 10.8% |
| CGC Canopy Growth | Q2 FY27 | $71.1M | +20% | -23.1% |
| JUSH Jushi Holdings | Q3 2026 | $70.5M | +7% | 5.0% |
Source: Leef Brands 10-Q on SEC EDGAR · CIK 1711141 · Medicinal Chemicals & Botanical Products
More on LEEEF
History
Every quarter: Q2 2026 results · Q1 2026 results